Context.— Dietary fish intake has been associated with a reduced risk of fatal
cardiac end points, but not with nonfatal end points. Dietary fish intake
may have a selective benefit on fatal arrhythmias and therefore sudden cardiac
death.
Objective.— To investigate prospectively the association between fish consumption
and the risk of sudden cardiac death.
Design.— Prospective cohort study.
Setting.— The US Physicians' Health Study.
Patients.— A total of 20551 US male physicians 40 to 84 years of age and free of
myocardial infarction, cerebrovascular disease, and cancer at baseline who
completed an abbreviated, semiquantitative food frequency questionnaire on
fish consumption and were then followed up to 11 years.
Main Outcome Measure.— Incidence of sudden cardiac death (death within 1 hour of symptom onset)
as ascertained by hospital records and reports of next of kin.
Results.— There were 133 sudden deaths over the course of the study. After controlling
for age, randomized aspirin and beta carotene assignment, and coronary risk
factors, dietary fish intake was associated with a reduced risk of sudden
death, with an apparent threshold effect at a consumption level of 1 fish
meal per week (P for trend=.03). For men who consumed
fish at least once per week, the multivariate relative risk of sudden death
was 0.48 (95% confidence interval, 0.24-0.96; P =.04)
compared with men who consumed fish less than monthly. Estimated dietary n-3
fatty acid intake from seafood also was associated with a reduced risk of
sudden death but without a significant trend across increasing categories
of intake. Neither dietary fish consumption nor n-3 fatty acid intake was
associated with a reduced risk of total myocardial infarction, nonsudden cardiac
death, or total cardiovascular mortality. However, fish consumption was associated
with a significantly reduced risk of total mortality.
Conclusion.— These prospective data suggest that consumption of fish at least once
per week may reduce the risk of sudden cardiac death in men.
SOME1-6
but not all7-10
prospective cohort studies of the association between fish consumption and
cardiovascular mortality have reported inverse associations. In general, fish
consumption has been associated with lower cardiac mortality in populations
characterized by low fish intake in which a substantial proportion rarely
or never consumed fish1-6
and not in those with higher levels of fish intake.7-10
Studies in which nonfatal coronary heart disease was examined have shown no
relationship.9,10 Randomized trial
data are limited, but 1 secondary prevention trial showed an association between
fish intake and reduction in cardiovascular mortality but not reinfarction.11 Based on these results, it has been hypothesized
that low levels of dietary fish intake may be unrelated to the incidence of
myocardial infarction, but could reduce coronary disease mortality by decreasing
fatal arrhythmias and therefore sudden cardiac death.12
Experimental data in dogs13 and primates14 suggest that the n-3 fatty acids in fish have antiarrhythmic
properties. Further, a retrospective case-control study found that, when compared
with no intake, n-3 fatty acid consumption equivalent to 1 fatty fish meal
per week was associated with a 50% reduction in the risk of primary cardiac
arrest,15 suggesting that antiarrhythmic effects
occur at the low levels of fish intake that have been associated with reduced
coronary heart disease mortality. Contrary to these findings, no association
was found between low levels of fish consumption and sudden death from myocardial
infarction in a recent prospective study,5
but a strong inverse association was observed with nonsudden death from myocardial
infarction as determined by death certificates. We addressed this controversy
further by prospectively examining the association between fish consumption
and sudden cardiac death ascertained from medical records and firsthand reports
among male physicians enrolled in the Physicians' Health Study.
The methods of the Physicians' Health Study have been described in detail
elsewhere.16,17 Briefly, 22071
US male physicians who were 40 to 84 years old in 1982 and had no history
of myocardial infarction, stroke, transient ischemic attack, or cancer (except
nonmelanoma skin cancer) were assigned at random using a 2-by-2 factorial
design to receive aspirin, beta carotene, both active drugs, or both placebos.
At baseline, the physicians completed questions on health status and risk
factors for cardiovascular disease, including alcohol and vitamin use, dietary
intake of selected foods, and exercise. Information on cardiovascular events
was updated every 6 months for the first year and annually thereafter through
brief follow-up questionnaires. Dietary intakes of selected foods were ascertained
by 2 abbreviated, semiquantitative food frequency questionnaires consisting
of 20 items each18 administered at 12 and 18
months. The 1988 (5-year follow-up) questionnaire inquired about current fish-oil
supplement use, but not about dose, frequency, or length of use.
Assessment of Fish Consumption
At 12 months, respondents were asked separately to indicate how often,
on average, they consumed 4 types of fish or shellfish: canned tuna fish;
dark meat fish (eg, mackerel, salmon, sardines, bluefish, or swordfish), 84
to 112 g; other fish, 84 to 112 g; and shrimp, lobster, or scallops as a main
dish. Seven response categories ranged from rarely/never to 2 or more per
day. We calculated average daily intake by summing the frequencies of the
4 fish or shellfish items. The nutrient intake of marine n-3 fatty acids was
estimated by multiplying the frequency of each item with the nutrient composition
of the portion of seafood (tuna, 0.69 g; dark fish, 1.37 g; other fish, 0.17
g; and shellfish, 0.46 g) and summing over all items. Nutrient composition
was based on US Department of Agriculture19
and other food composition tables.20
Reproducibility and validity of the 4 questionnaire items on seafood
intake were assessed in a study of 127 male health professionals aged 45 to
70 years.21,22 The correlation
between 2 administrations of the questionnaires 1 year apart ranged from 0.48
for fish to 0.67 for shellfish.21 Validity
of the questionnaire was assessed by comparing fish intake as reported on
the questionnaire with fish intake ascertained from two 1-week dietary records
obtained about 6 months apart (Spearman correlation coefficient=0.61; P<.001)21 and by comparing
the dietary intake of n-3 fatty acids estimated from the questionnaire to
the percentage measured in adipose tissue of 118 of the 127 men (Spearman
correlation coefficient=0.49; P <.001).22
The ascertainment of cardiovascular disease events was by self-report
on follow-up questionnaires, and deaths were generally reported by postal
authorities or next of kin. All such events were reviewed by an end points
committee of 4 physicians for confirmation by medical records obtained from
hospitals and attending physicians. Records were reviewed for 95.6% of the
myocardial infarctions and 94.8% of the deaths. The next of kin was interviewed
regarding the circumstances surrounding the death if it was not adequately
documented in the medical record. Cases of nonfatal myocardial infarction
were confirmed with the use of the World Health Organization criteria23; all cases had documentation of symptoms and either
electrocardiographic changes or elevated serum cardiac enzyme levels consistent
with infarction. Silent myocardial infarctions were not included because they
could not be dated accurately. All fatal myocardial infarctions were confirmed
by hospital records or autopsy. Deaths due to a cardiovascular cause (International Classification of Diseases, Ninth Revision
[ICD-9] codes 390-459) were confirmed by convincing
evidence of a cardiovascular mechanism from all available sources, including
death certificates, hospital records, autopsy reports, symptoms, and circumstances
of death. These deaths included cardiac, cerebrovascular, and vascular deaths.
Deaths in which there was evidence of coronary heart disease at or prior to
death and in which a noncoronary cause of death was not found were classified
as coronary heart disease deaths (ICD-9 codes 410-414).
Deaths that occurred within 1 hour of the onset of symptoms were also classified
as coronary heart disease deaths unless there was evidence to the contrary,
because these deaths are primarily due to coronary heart disease in autopsy
series. If a participant experienced a nonfatal myocardial infarction prior
to death, both end points were included in the analyses.
To ascertain the specific end point of sudden cardiac death, medical
records and reports from next of kin of all cardiovascular deaths (excluding
strokes) were re-reviewed by 2 cardiologists unaware of exposure status, and
agreement was reached. Sudden death was defined as death within 1 hour of
symptom onset, a witnessed cardiac arrest, or both, or abrupt collapse not
preceded by more than 1 hour of symptoms that precipitated the terminal event.
Information from the death certificate was not used in the determination of
the timing of death. To increase our specificity for arrhythmic death, we
excluded any patient who had evidence of collapse of the circulation (hypotension,
exacerbation of congestive heart failure, or altered mental status) prior
to the disappearance of the pulse. Finally, no other probable cause of death
other than cardiac was suggested by history or autopsy.
Unwitnessed deaths with no information on timing but with an autopsy
consistent with arrhythmic cardiac death (ie, acute coronary thrombosis or
severe coronary artery disease without myocardial necrosis or other pathologic
findings to explain death) were considered possible sudden cardiac deaths,
and the analysis was performed both including and excluding these deaths.
Nonsudden cardiac deaths were defined as deaths in which the length of symptoms
prior to death was greater than 1 hour. Deaths (often unwitnessed) in which
the timing could not be determined accurately from the available information
were not classified.
We excluded 620 physicians who either died prior to returning or failed
to return the 12-month questionnaire or to answer 2 or more questions regarding
fish consumption. To minimize misclassification in the lowest categories of
dietary fish intake, we excluded 123 physicians who had missing information
for 1 of the 4 seafood questions and responses of "rarely/never" or "1-3 times
per month" for the remaining 3. We also excluded 777 physicians who reported
fish-oil supplement use on the 1988 questionnaire, because the focus of this
study was on dietary intake, and the dose and the date of initiation of supplements
were not known. These exclusions yielded a study population of 20551. We did
not exclude participants who developed evidence of cardiovascular disease
during follow-up, but controlled for evidence of cardiovascular
disease prior to the return of the 12-month questionnaire in the multivariate
model because prior disease may have influenced fish consumption.
Participants contributed follow-up time from the date of return of the
12-month questionnaire to date of death or to the scheduled end of the randomized
beta carotene component of the study on December 31, 1995, whichever came
first. To detect differences in relative risks (RRs) at low levels of fish
intake, men who answered rarely/never to all 4 fish questions were used as
the reference group for all analyses, and the fish consumers were categorized
into 4 categories that emphasized the low levels of intake (1-3 meals per
month, 1-2 meals per week, 2-5 meals per week, ≥5 meals per week) rather
than equal quartiles. For n-3 fatty acid intake, the men who ate any fish
were grouped into equal quartiles of intake and compared with the reference
category who rarely or never ate fish.
Relative risks were computed using Cox proportional hazards models,24 controlling for age and randomized aspirin and beta
carotene assignment. A multivariate Cox proportional hazards model was used
to control for potential confounders, including prior cardiovascular disease,
body mass index, smoking status, history of diabetes, history of hypertension,
history of hypercholesterolemia, alcohol consumption, vigorous exercise, and
use of vitamin E, vitamin C, and multivitamins. Other dietary factors (red
meat, vegetables, fruits, dairy, chicken or turkey, and fried foods) were
tested individually for associations with sudden cardiac death in separate
Cox models, and each was entered into the multivariate model to test for confounding.
Tests for trend were performed by assigning an ordinal variable for each level
of consumption and modeling this as a continuous variable in separate Cox
proportional hazards models. For each RR, 2-sided P
values and 95% confidence intervals (CIs) were calculated. The relationships
between both fish intake and n-3 fatty acid intake and risk of sudden death
were explored further using spline regression modeling. Restricted cubic spline
models with 4 or 5 knots were used to flexibly model these relationships using
measured values of fish or n-3 fatty acid intake and avoiding the need for
prior specification of the RR function or the location of a threshold exposure
value.25
Of the 20551 men included in this analysis, 637 (3.1%) reported rarely
or never consuming fish, and 2212 (10.8%) reported consuming fish at least
5 times weekly. Most (80%) consumed fish between 1 and 4 times per week, and
the mean level of consumption was 2.5 meals per week. Dietary fish intake
and n-3 fatty acid intake were associated with several coronary risk factors
(Table 1). Men who consumed more
fish tended to be at higher risk because of a history of high cholesterol
levels or hypertension or a family history of coronary heart disease. However,
they were also more likely to exercise vigorously at least once per week and
use antioxidant vitamin supplements. Fish intake was also directly or indirectly
associated with a variety of dietary factors (Table 1). We therefore analyzed the relation of fish consumption
(and n-3 fatty acid intake) to sudden death, with and without adjustment for
all these variables.
Over 11 years and 253777 person-years of follow-up, 133 sudden deaths
(115 definite and 18 probable) were documented. After adjustment for age and
aspirin and beta carotene assignment, fish consumption was inversely related
to the risk of sudden cardiac death (Table
2) with a significant trend (P=.03) across
5 levels of dietary fish consumption. Compared with men who ate fish less
than once per month, the age-adjusted RR of sudden death for those who consumed
fish in any amount was consistently reduced. This inverse association reached
significance at a consumption level of between 1 and 2 servings of fish per
week with an RR of 0.42 (P=.02), with minimal change
in this reduction at higher levels of consumption. When men who ate fish at
least once per week were analyzed together in a secondary analysis, the trend
across the 3 categories was more extreme (uncorrected P=.006; significant after Bonferroni correction, P=.04) (Table 2).
After further adjustment for coronary risk factors and prior cardiovascular
disease, these relationships were not substantially altered, except the P for trend was no longer significant across 5 fish categories
but remained significant across 3 (number of fish meals <1 per month, 1-3
per month, ≥1 per week), compatible with a possible threshold effect at
1 fish meal per week. However, the test for trend across the 3 categories
would be judged of borderline significance after Bonferroni correction for
the 6 possible ways to retabulate the prior 5 categories (significance criterion, P =.008). A smooth model of the relationship between number
of fish meals per week as a continuous function and the relative hazard of
sudden cardiac death after multivariate adjustment is shown in Figure 1. This model uses average daily fish intake and permits
risk comparison across low exposures without arbitrary categorization or selection
of a priori threshold values. A similar relationship suggesting a threshold
effect was found, but the CIs were wide.
All other food groups tested individually (red meat, chicken, vegetables,
fruits, dairy, and fried foods) were not significantly associated with sudden
cardiac death. The separate addition of these food groups to the multivariate
model did not alter the association between fish intake and sudden cardiac
death. In analyses according to type of fish, the multivariate RR for men
who consumed fish at least once per week as compared with those who consumed
less than 1 serving per month was 0.66 (95% CI, 0.40-1.11) for tuna, 0.98
(95% CI, 0.56-1.70) for dark meat fish, 0.63 (95% CI, 0.39-1.04) for other
fish, and 0.69 (95% CI, 0.35-1.34) for shellfish. These results are consistent
with a possible beneficial effect across various fish categories. For dark
meat fish, the point estimate was close to 1.0; however, the CIs for this
type of fish were wide and do not exclude the degree of protection seen for
other types of fish.
The relationship of estimated intake of n-3 fatty acids with sudden
death is shown in Table 3. The
mean monthly n-3 fatty acid intake was 5.9 g, which is roughly equivalent
to 1 fatty fish meal per week. The reference group rarely or never consumed
fish and therefore had a n-3 fatty acid intake from marine sources essentially
equal to zero (<0.3 g per month). The remainder who consumed fish were
separated into quartiles of n-3 fatty acid intake. There was no significant
linear trend across quartiles of n-3 fatty acid intake in either the age-adjusted
or the multivariate analyses, but the men who consumed any quantity of n-3
fatty acids had a decreased RR of sudden death (although this reduction was
not significant in all quartiles). Spline regression modeling also suggested
the existence of a plateau of risk at low intakes, but the CIs were wide (Figure 2).
Other Cardiovascular End Points
There were 737 incident myocardial infarctions during the 11 years of
follow-up. In contrast to the inverse relationship with sudden cardiac death,
dietary fish consumption and n-3 fatty-acid intake were not associated with
myocardial infarction (Table 4).
Men who consumed any amount of fish more than once per month had a risk of
myocardial infarction equivalent to those who consumed fish less than once
per month. Fish consumption also was not significantly associated with nonsudden
cardiac death (terminal illness >1 hour) or with risk of coronary heart disease
death or total cardiovascular death over either 3 or 5 categories of fish
intake (Table 5). However, fish
consumption at a level of 1 fish meal per week was associated with a statistically
significant reduction in the risk of total mortality after multivariate adjustment
(RR for ≥1 meals per week vs <1 meal per month=0.70; 95% CI, 0.55-0.89),
with a similar relationship (an apparent threshold at 1-<2 meals per week)
to that seen with sudden cardiac death (P for trend
across 3 categories=.003; significant after Bonferroni correction, P=.02) (Table 5).
In this large, prospective cohort study of US male physicians, low to
moderate intake of fish—at least 1 fish meal per week—was associated
with a 52% lower risk of sudden death compared with less than monthly consumption,
even after controlling for several confounders. All levels of fish consumption
were associated with a decreased risk of sudden death, but the size of the
reduction did not appear to differ substantially at levels of consumption
greater than 1 fish serving per week, suggesting a threshold effect. This
small amount of fish may be sufficient to provide an essential amount of long-chain
n-3 polyunsaturated fatty acid or some unidentified nutrient or both that
decrease sudden cardiac death. The effect was consistent across most categories
except for dark meat fish. If n-3 fatty acids are indeed the active agent,
this result is somewhat surprising, because this type of fish has the highest
n-3 fatty acid content. However, considering that the CIs were wider for this
type of fish and included the degree of protection seen for the other types
of fish, a possible benefit for this type of fish cannot be excluded.
When total marine n-3 fatty acid intake was estimated, any intake was
associated with a decreased risk of sudden death compared with no intake,
but there was no suggestion of a linear dose-response relationship. The lack
of a clear dose-response trend and the results for dark meat fish raise the
possibility that some other nutrient(s) may play a role in explaining the
protective effect of fish consumption on sudden death. Alternatively, if the
dose of n-3 fatty acids required for a protective effect was small, these
data could be consistent with n-3 fatty acids being the essential nutrient.
Also, any significant imprecision in the estimate could have obscured a dose
response, especially at the low levels. Our assessment of total n-3 fatty
acid intake was subject to both random measurement error and underestimation
error owing to a lack of information on α-linolenic acid consumption
(an 18-carbon n-3 fatty acid found in unhydrogenated soybean oil, canola oil,
and some nuts), which also may have antiarrhythmic properties and can be elongated
to eicosapentanoic acid.26 Both types of errors
would tend to reduce or obscure any real association with n-3 fatty acids
and may explain the lack of a clear trend.
There was no evidence of any association, in contrast to that seen with
sudden cardiac death, between dietary fish (or n-3 fatty acid) intake and
the risk of myocardial infarction. This finding is consistent with previous
reports in this9,27 and other
prospective observational studies10 as well
as a secondary prevention trial.11 The Diet
and Reinfarction Trial, which randomized 2033 men after myocardial infarction
to receive or not to receive advice to eat at least 2 portions of fatty fish
per week, found no difference in the incidence of nonfatal myocardial infarctions
between treatment groups at 2 years. Despite this, total mortality (primarily
composed of ischemic heart disease deaths) was reduced significantly by 29%
in the intervention group. The authors hypothesized that fish consumption
may reduce the risk of fatal arrhythmias and therefore mortality after myocardial
infarction without affecting the incidence of repeat myocardial infarction.
The differential effect on myocardial infarction and sudden death in our prospective
study supports this hypothesis, since 91% to 98% of these deaths, as defined,
would be expected to be due to a fatal arrhythmia.28,29
A component of fish may have antiarrhythmic properties that reduce the
vulnerability to life-threatening arrhythmias during cardiac ischemia.12-14 Consumption of 1
fish meal per week compared with no fish has been associated with an increase
in heart rate variability,30 which has been
associated with a lower risk of arrhythmic death after myocardial infarction.31 There was little added benefit at higher levels of
consumption, as seen in our study. A retrospective, population-based case-control
study of primary cardiac arrest provides support for antiarrhythmic effects
of fish.15 This study found an association
between both dietary intake of n-3 fatty acids from fish and red blood cell
n-3 fatty acid composition and a reduced risk of primary cardiac arrest. Also,
a decreased risk was seen even at low levels of fish consumption (2 fatty
fish meals per month), and a similar reduction was seen at 1 fish meal per
week (50% decreased risk). Our study adds to this evidence by demonstrating
a similar relationship prospectively between fish and sudden cardiac death
in a defined cohort of men.
However, another prospective study found seemingly contradictory results.
The Western Electric study5 reported an association
between fish consumption at low doses and a reduced risk of nonsudden but
not sudden death from myocardial infarction among 1822 men followed up for
30 years. A major difference between that study and ours was the method used
to ascertain the end point of sudden death. The Western Electric study used
death certificates alone to determine the specific type of coronary heart
disease death and whether deaths from myocardial infarction were sudden. We
used next of kin reports, medical records, and autopsy results to determine
the timing of all cardiac deaths (not just those in which myocardial infarction
was listed as the cause of death on a death certificate). The rate of misclassification
is high and assessment of timing of death may not be valid when death certificate
information is not supplemented with hospital records, autopsy data, or interviews
with next of kin.32,33 Kuller
et al34 found that, even when the probability
of sudden death ascertained from information on the death certificate was
thought to be high, 50% ultimately were found to be nonsudden deaths when
all available information was used.
Our study has several limitations. As with any observational study,
the association between fish consumption and sudden cardiac death could, at
least in part, be due to residual confounding. Fish consumption may be a marker
for a healthier lifestyle. In these data, fish consumers were more likely
to exercise regularly and to take antioxidant vitamin supplements. However,
fish consumption was not a marker for a lower risk of myocardial infarction,
which is also a consequence of a healthier lifestyle. Alternatively, fish
consumers may be at higher self-perceived risk for coronary heart disease
and are eating fish and practicing other healthy lifestyle behaviors to reduce
their higher baseline risk. In support of this possibility, fish consumers
were more likely to have a history of hypertension or hypercholesterolemia
and a family history of coronary heart disease. The net effect of these interrelationships
on risk of sudden death is unclear, but these complex relationships may account
for part or all of the association between fish consumption and sudden cardiac
death. In addition, only 637 men reported consuming fish less than once a
week, and these men may have other unusual characteristics not accounted for
in our multivariate model and that may have influenced their risk for sudden
death.
Since we did not collect complete information on diet, our study cannot
exclude the possibility that some other dietary factor associated with fish
consumption could be responsible for the observed association. But when we
controlled for intake of red meat, vegetables, fruits, dairy products, fried
foods, saturated fat, and beta carotene from the limited information (40 questions)
collected, the relationships between fish and sudden cardiac death were essentially
unchanged. None of these food groups was independently associated with sudden
cardiac death, and the evidence supporting an antiarrhythmic property of fish
is greater. Another important limitation of our study is the single measure
of fish consumption and, therefore, the inability to account for changes in
intake over time, which also would tend to obscure associations if the effect
of fish intake or n-3 fatty acid intake is of short duration.
Despite the beneficial association between fish consumption and sudden
cardiac death, our study did not show a significant benefit on total cardiovascular
disease mortality (or coronary heart disease mortality) and therefore is discordant
with some1-6
but not all7-10
prospective cohort studies. In general, fish consumption has been associated
with lower cardiac mortality in populations characterized by low fish intake
in which a substantial proportion rarely or never consumed fish,1-6
but not in those with high levels of fish intake, in which few individuals
rarely or never consumed fish.7-10
Most studies reporting inverse associations found a benefit at a level of
consumption at or around 30 g per day or 1 fish meal per week,1,5
the same low levels at which fish consumption was associated with a possible
antiarrhythmic effect in our study and in the study by Siscovick et al.15 If there were a threshold effect at 1 fish meal per
week, this could explain, at least in part, the apparently discordant result
on cardiovascular mortality among observational studies. In our study, only
3.1% of the population rarely or never consumed fish and were therefore at
highest risk for sudden death. Accordingly, less than 30% of the coronary
heart disease deaths occurred suddenly. Therefore, the observed reduction
in cardiovascular mortality associated with fish consumption was only modest
(11%) and not significant.
The inverse relationship with total mortality without a significant
relationship on cardiovascular mortality suggests that there may be associations
between fish consumption and other noncardiac causes of death. The n-3 fatty
acids are important components of all cell membranes,35
have been demonstrated to have anti-inflammatory effects, and may have beneficial
effects on ulcerative colitis, rheumatoid arthritis,35
and asthma.36 Epidemiologic data4,37,38
suggest that fish consumption and n-3 fatty acids may have a beneficial effect
on certain types of cancers. Also, if fish intake decreased the risk of developing
ventricular arrhythmias to a variety of insults such as hypoxia, electrolyte
disturbances, and acidosis, then it might influence the risk of dying from
diverse causes resulting in an overall benefit on total mortality. Although
not clearly explained here, the effect on total mortality is both reassuring
and intriguing and clearly warrants further study.
Approximately 250000 sudden cardiac deaths occur in the United States
every year.39 Of these sudden deaths, 55% have
no previous history of heart disease,40 and
most die prior to reaching the hospital. Of persons with cardiac arrest who
do reach the hospital, only 30% will be discharged alive.41
Any substantial reduction in arrhythmic and therefore sudden death will require
primary prevention efforts in the general population and not just in those
with a history of coronary heart disease. If the observed inverse association
between low to moderate levels of fish consumption and a reduced risk of sudden
death is causal, the public health impact of such an intervention could be
substantial, depending on the percentage of the population in the United States
and other countries currently eating fish less than weekly. While large-scale
randomized trials are necessary to confirm or refute these findings, our data
add to the existing totality of evidence that consuming at least 1 meal of
fish per week may substantially reduce the risk of sudden cardiac death.
1.Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality
from coronary heart disease.
N Engl J Med.1985;312:1205-1209.Google Scholar 2.Norell SE, Ahlbom A, Feychting M, Pederson NL. Fish consumption and mortality from coronary heart disease.
Br Med J (Clin Res Ed).1986;293:426.Google Scholar 3.Shekelle RB, Missell LV, Paul O, Shyrock AM, Stamler J. Fish consumption and mortality from coronary heart disease.
N Engl J Med.1985;313:820.Google Scholar 4.Dolecek TA. Epidemiological evidence of relationships between dietary polyunsaturated
fatty acids and mortality in the Multiple Risk Factor Intervention Trial.
Proc Soc Exp Biol Med.1992;200:177-182.Google Scholar 5.Daviglus ML, Stamler J, Orencia AJ.
et al. Fish consumption and the 30-year risk of fatal myocardial infarction.
N Engl J Med.1997;336:1046-1053.Google Scholar 6.Kromhout D, Feskens EJM, Bowles CH. The protective effect of a small amount of fish on coronary heart disease
mortality in an elderly population.
Int J Epidemiol.1995;24:340-345.Google Scholar 7.Vollset SE, Heuch I, Bjelke E. Fish consumption and mortality from coronary heart disease.
N Engl J Med.1985;313:820-821.Google Scholar 8.Curb JD, Reed DM. Fish consumption and mortality from coronary heart disease.
N Engl J Med.1985;313:820-824.Google Scholar 9.Morris MC, Manson JE, Rosner B, Buring JE, Willett WC, Hennekens CH. Fish consumption and cardiovascular disease in the Physicians' Health
Study: a prospective study.
Am J Epidemiol.1995;142:166-175.Google Scholar 10.Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk
of coronary disease among men.
N Engl J Med.1995;332:977-982.Google Scholar 11.Burr ML, Fehily AM, Gilbert JF.
et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial
reinfarction.
Lancet.1989;2:757-761.Google Scholar 12.Kang JX, Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids: recent studies.
Circulation.1996;94:1774-1780.Google Scholar 13.Billman GE, Hallaq H, Leaf A. Prevention of ischemia-induced ventricular fibrillation by ω3
fatty acids.
Proc Natl Acad Sci U S A.1994;91:4427-4430.Google Scholar 14.McLennan PL, Bride TM, Abeywardena MY, Charnock JS. Dietary lipid modulation of ventricular fibrillation threshold in the
marmoset monkey.
Am Heart J.1992;123:1555-1561.Google Scholar 15.Siscovick DS, Raghunathan TE, King I.
et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated
fatty acids and the risk of primary cardiac arrest.
JAMA.1995;274:1363-1367.Google Scholar 16.The Steering Committee of the Physicians' Health Study Research Group. Preliminary report: findings from the aspirin component of the ongoing
Physicians' Health Study.
N Engl J Med.1988;318:262-264.Google Scholar 17.The Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health
Study.
N Engl J Med.1989;321:129-135.Google Scholar 18.Willett WC, Sampson L, Stampfer MJ.
et al. Reproducibility and validity of a semiquantitative food frequency questionnaire.
Am J Epidemiol.1985;122:51-65.Google Scholar 19.US Dept of Agriculture. Composition of Foods . Washington, DC: US Government Printing Office; 1963-1988. Agricultural
Handbook Series No. 8.
20.Hepburn FN, Exler J, Weihrauch JL. Provisional tables of omega-3 fatty acids and other fat components
of selected foods.
J Am Diet Assoc.1986;86:788-793.Google Scholar 21.Feskanich D, Rimm EB, Giovanucci EL.
et al. Reproducibility and validity of food intake measurements from a semiquantitative
food frequency questionnaire.
J Am Diet Assoc.1993;93:790-796.Google Scholar 22.Hunter DJ, Rimm EB, Sacks FM.
et al. Comparison of measures of fatty acid intake by subcutaneous fat aspirate,
food frequency questionnnaire, and diet records in a free-living population
of US men.
Am J Epidemiol.1992;135:418-427.Google Scholar 23.World Health Organization. Ischaemic Heart Disease Registers: Report of the Fifth Working
Group (Including a Second Revision of the Operating Protocol) . Copenhagen, Denmark: Regional Office for Europe, World Health Organization;
1971.
24.Cox D. Regression models and life-tables.
J R Stat Soc Br.1972;34:187-220.Google Scholar 25.Greenland S. Dose-response and trend analysis in epidemiology.
Epidemiology.1995;6:356-365.Google Scholar 26.de Logreril M, Renaud S, Mamelle N.
et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention
of coronary heart disease.
Lancet.1994;343:1454-1459.Google Scholar 27.Guallar E, Hennekens CH, Sacks FM, Willett WC, Stampfer MJ. A prospective study of plasma fish oil levels and the incidence of
myocardial infarction in US male physicians.
J Am Coll Cardiol.1995;25:387-394.Google Scholar 28.Hinkle LE, Thaler HT. Clinical classification of cardiac deaths.
Circulation.1982;65:457-464.Google Scholar 29.Goldstein S, Friedman L, Hutchinson R.
et al. Timing, mechanism and clinical setting of witnessed deaths in postmyocardial
infarction patients.
J Am Coll Cardiol.1984;3:1111-1117.Google Scholar 30.Christensen JH, Korup E, Aaroe J.
et al. Fish consumption, n-3 fatty acids in cell membranes, and heart rate
variability in survivors of myocardial infarction with left ventricular dysfunction.
Am J Cardiol.1997;79:1670-1673.Google Scholar 31.Hartikainen JK, Malik M, Staunton A, Poloniecki J, Camm J. Distinction between arrhythmic and nonarrhythmic death after acute
myocardial infarction based on heart rate variability, signal-average electrocardiogram,
ventricular arrhythmias and left ventricular ejection fraction.
J Am Coll Cardiol.1996;28:296-304.Google Scholar 32.Kircher T, Nelson J, Burdo H. The autopsy as a measure of accuracy of the death certificate.
N Engl J Med.1985;313:1263-1269.Google Scholar 33.Dobson AJ, Gibberd RW, Leeder SR. Death certificate and coding for ischemic heart disease in Australia.
Am J Epidemiol.1983;117:397-405.Google Scholar 34.Kuller L, Lilienfeld A, Fisher R. An epidemiological study of sudden and unexpected deaths in adults.
Medicine (Baltimore).1967;46:341-361.Google Scholar 35.Simopoulis AP. Omega-3 fatty acids in health and disease and in growth and development.
Am J Clin Nutr.1991;54:438-463.Google Scholar 36.Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM. Reduced asthma symptoms with n-3 fatty acid ingestion are related to
5-series leukotriene production.
Am J Clin Nutr.1997;65:1011-1017.Google Scholar 37.Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE. Relation of meat, fat, and fiber intake to the risk of colon cancer
in a prospective study among women.
N Engl J Med.1990;323:1664-1672.Google Scholar 38.Mishina T, Wantanabe H, Araki N, Nakao M. Epidemiologic study of prostate cancer by matched-pair analysis.
Prostate.1985;6:423-436.Google Scholar 39.American Heart Association. Heart and Stroke Facts: 1995 Statistical Supplement . Dallas, Tex: American Heart Association; 1995.
40.Kannel WB, Cupples LA, D'Agostino RB. Sudden death risk in overt coronary heart disease: the Framingham Study.
Am Heart J.1987;113:799-804.Google Scholar 41.Valenzuela TD, Spaite DW, Meislin HW, Clark LL, Wright AL, Ewy GA. Case and survival definitions in out-of-hospital cardiac arrest.
JAMA.1992;267:272-274.Google Scholar